⟵ Back to Search Results

BGB-A317-A1217-301

Recruiting

Tislelizumab Plus BGB-A1217 Versus Tislelizumab Versus Durvalumab When Co-administered With Concurrent Chemoradiotherapy (cCRT) in Lung Cancer

Beigene Study ID info

BGB-A317-A1217-301

ClinicalTrials.gov ID info

NCT04866017

EudraCT Number info

2020-004656-14

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents